BRPI0810496A2 - inibidores de transcriptase reversa de não-nucleosídeo - Google Patents

inibidores de transcriptase reversa de não-nucleosídeo

Info

Publication number
BRPI0810496A2
BRPI0810496A2 BRPI0810496A BRPI0810496A BRPI0810496A2 BR PI0810496 A2 BRPI0810496 A2 BR PI0810496A2 BR PI0810496 A BRPI0810496 A BR PI0810496A BR PI0810496 A BRPI0810496 A BR PI0810496A BR PI0810496 A2 BRPI0810496 A2 BR PI0810496A2
Authority
BR
Brazil
Prior art keywords
reverse transcriptase
transcriptase inhibitors
nucleoside reverse
nucleoside
inhibitors
Prior art date
Application number
BRPI0810496A
Other languages
English (en)
Inventor
Wu Jeffrey
J Billedeau Roland
Solang Palmer Wylie
Kevin Sweeney Zachary
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0810496A2 publication Critical patent/BRPI0810496A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0810496A 2007-04-09 2008-03-31 inibidores de transcriptase reversa de não-nucleosídeo BRPI0810496A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92244907P 2007-04-09 2007-04-09
US96134607P 2007-07-20 2007-07-20
PCT/EP2008/053806 WO2008122534A2 (en) 2007-04-09 2008-03-31 Non-nucleoside reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
BRPI0810496A2 true BRPI0810496A2 (pt) 2018-11-06

Family

ID=39798124

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810496A BRPI0810496A2 (pt) 2007-04-09 2008-03-31 inibidores de transcriptase reversa de não-nucleosídeo

Country Status (15)

Country Link
US (1) US20080293664A1 (pt)
EP (1) EP2134711A2 (pt)
JP (1) JP2010523613A (pt)
KR (1) KR20100015435A (pt)
CN (1) CN101679414A (pt)
AR (1) AR066404A1 (pt)
AU (1) AU2008235549A1 (pt)
BR (1) BRPI0810496A2 (pt)
CA (1) CA2683046A1 (pt)
CL (1) CL2008000996A1 (pt)
IL (1) IL200886A0 (pt)
MX (1) MX2009010932A (pt)
PE (1) PE20090143A1 (pt)
TW (1) TW200906410A (pt)
WO (1) WO2008122534A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006078891A2 (en) * 2005-01-21 2006-07-27 Neurogen Corporation Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives
JP5269087B2 (ja) * 2007-11-16 2013-08-21 ギリアード サイエンシス インコーポレーテッド ヒト免疫不全ウイルス複製のインヒビター
AU2008340422B2 (en) * 2007-12-21 2014-06-19 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
CA2803103A1 (en) 2010-07-15 2012-01-19 Albemarle Corporation Processes for producing 4-bromo-2-methoxybenzaldehyde
US9497234B2 (en) 2012-12-27 2016-11-15 Facebook, Inc. Implicit social graph connections
WO2016004305A2 (en) * 2014-07-02 2016-01-07 Pharmacyclics Llc Inhibitors of bruton's tyrosine kinase

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128287D0 (en) * 2001-11-26 2002-01-16 Smithkline Beecham Plc Novel method and compounds
GB0206723D0 (en) * 2002-03-21 2002-05-01 Glaxo Group Ltd Novel compounds
WO2004085406A1 (en) * 2003-03-24 2004-10-07 F. Hoffmann-La Roche Ag Benzyl-pyridazinons as reverse transcriptase inhibitors
TW200505441A (en) * 2003-03-24 2005-02-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitorsⅠ
EP1730120A1 (en) * 2004-03-23 2006-12-13 F.Hoffmann-La Roche Ag Non-nucleoside reverse transcriptase inhibitors
US7166738B2 (en) * 2004-04-23 2007-01-23 Roche Palo Alto Llc Non-nucleoside reverse transcriptase inhibitors
US7625949B2 (en) * 2004-04-23 2009-12-01 Roche Palo Alto Llc Methods for treating retroviral infections
ES2391461T3 (es) * 2004-07-27 2012-11-27 F. Hoffmann-La Roche Ag Compuestos de benciltriazolona utilizados como inhibidores no nucleósidos de transcriptasa inversa
AR057455A1 (es) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
DE602007013573D1 (de) * 2006-08-16 2011-05-12 Hoffmann La Roche Nicht-nukleosidische reverse-transkriptase-hemmer

Also Published As

Publication number Publication date
EP2134711A2 (en) 2009-12-23
CA2683046A1 (en) 2008-10-16
WO2008122534A2 (en) 2008-10-16
US20080293664A1 (en) 2008-11-27
CL2008000996A1 (es) 2008-10-10
AU2008235549A1 (en) 2008-10-16
CN101679414A (zh) 2010-03-24
AR066404A1 (es) 2009-08-19
IL200886A0 (en) 2010-05-17
TW200906410A (en) 2009-02-16
JP2010523613A (ja) 2010-07-15
PE20090143A1 (es) 2009-02-26
WO2008122534A3 (en) 2009-02-05
KR20100015435A (ko) 2010-02-12
MX2009010932A (es) 2009-10-29

Similar Documents

Publication Publication Date Title
BRPI0813269A2 (pt) Inibidores de hiv transcriptase reversa
BRPI0715193A2 (pt) inibidores nço-nucleosÍdicos da transcriptase reversa
IL199103A0 (en) Non-nucleoside reverse transcriptase inhibitors
EP2076492A4 (en) NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS
IL205386A0 (en) Non - nucleoside reverse transcriptase inhibitors
LTPA2019506I1 (lt) Nenukleozidinės reversinės transkriptazės inhibitoriai
EP2217069A4 (en) INHIBITORS OF NON-NUCLEOSIDE INHIBITORS OF THE REVERSE TRANSCRIPTASE
CY2017016I1 (el) Αναστολεις πρωτεασωματος
EP2220091A4 (en) REVERSE transcriptase inhibitors
IL200748A0 (en) Non-nucleoside reverse transcriptse inhibitors
BRPI0818294A2 (pt) refrigerador
DK2139892T3 (da) Substituerede pyrimidodiazepiner nyttige som PLK1-inhibitorer
NO20161397A1 (no) Ikke-nukleosidbaserte revers-transkriptase-inhibitorer
DK2383271T3 (da) Aminoquinoloner som GSK-3-inhibitorer
BRPI0819260A2 (pt) refrigerador
BRPI0820345A2 (pt) refrigerador
EP2226593A4 (en) FREEZER UNIT
EP2204584A4 (en) Screw fluid machine
BRPI0811645A2 (pt) Inibidores de transcriptase reversa de não-nucleosídeo
IL200886A0 (en) Non-nucleoside reverse transcriptase inhibitors
BRPI0714509A2 (pt) Inibidores de transcriptase reversa de não-nucleosídeo.
EP1899340A4 (en) NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS
FI20075320A0 (fi) Uusia käyttökelpoisia inhibiittoreita
HK1131985A (en) Non-nucleoside reverse transcriptase inhibitors
FIU20070349U0 (fi) Talutin

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]